These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7117089)

  • 1. Indomethacin and the preterm infant with a patent ductus arteriosus: relationship between plasma concentration and ductus closure.
    Friedman CA; Parks BR; Rawson JE; Serwer GA; Anderson PA
    Dev Pharmacol Ther; 1982; 4(1-2):37-46. PubMed ID: 7117089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum indomethacin concentrations after intravenous administration to preterm infants with patent ductus arteriosus.
    Petersen S; Christensen NC; Møller Jensen K; Ryssing E
    Acta Paediatr Scand; 1981 Sep; 70(5):729-33. PubMed ID: 7324922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin therapy in premature infants with patent ductus arteriosus and oliguria.
    Yeh TF; Wilks A; Luken J; Pildes RS
    Dev Pharmacol Ther; 1986; 9(6):369-74. PubMed ID: 3816491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma indomethacin levels in preterm newborn infants with symptomatic patent ductus arteriosus--clinical and echocardiographic assessments of response.
    Alpert BS; Lewins MJ; Rowland DW; Grant MJ; Olley PM; Soldin SJ; Swyer PR; Coceani F; Rowe RD
    J Pediatr; 1979 Oct; 95(4):578-82. PubMed ID: 480038
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and clinical efficacy of indomethacin in premature infants with patent ductus arteriosus.
    Regazzi MB; Rondanelli R; Vidale E; Chirico G; Rondini G; Chiara A; Piccolo A
    Int J Clin Pharmacol Res; 1984; 4(2):109-12. PubMed ID: 6469435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indomethacin treatment in small versus large premature infants with ductus arteriosus. Comparison of plasma indomethacin concentration and clinical response.
    Yeh TF; Luken J; Raval D; Thalji A; Carr I; Pildes RS
    Br Heart J; 1983 Jul; 50(1):27-30. PubMed ID: 6860508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels.
    Yeh TF; Achanti B; Patel H; Pildes RS
    Dev Pharmacol Ther; 1989; 12(4):169-78. PubMed ID: 2766920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indomethacin therapy of patent ductus in preterm infants controlled by plasma levels.
    Lewis IG; Harvey DP; Maxwell GM
    Aust Paediatr J; 1985 Aug; 21(3):181-3. PubMed ID: 4062716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels.
    O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM
    Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
    Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
    Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of indomethacin in the neonate. Relation of plasma indomethacin levels to response of the ductus arteriosus.
    Brash AR; Hickey DE; Graham TP; Stahlman MT; Oates JA; Cotton RB
    N Engl J Med; 1981 Jul; 305(2):67-72. PubMed ID: 7242577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide in the diagnosis of patent ductus arteriosus.
    Weir FJ; Smith A; Littleton P; Carter N; Hamilton PA
    Acta Paediatr; 1992 Sep; 81(9):672-5. PubMed ID: 1421905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenously administered indomethacin in premature infants.
    Thalji AA; Carr I; Yeh TF; Raval D; Luken JA; Pildes RS
    J Pediatr; 1980 Dec; 97(6):995-1000. PubMed ID: 7441434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of symptomatic patent ductus arteriosus in extremely premature infants, treated with indomethacin.
    Mellander M; Leheup B; Lindstrom DP; Palme C; Graham TP; Stahlman MT; Cotton RB
    J Pediatr; 1984 Jul; 105(1):138-43. PubMed ID: 6737129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting oliguria following indomethacin for treatment of patent ductus arteriosus.
    Barrington KJ; Fox M
    Am J Perinatol; 1994 May; 11(3):220-2. PubMed ID: 8048989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.